» Articles » PMID: 30593829

Functional Interdependence of Hematopoietic Stem Cells and Their Niche in Oncogene Promotion of Myeloproliferative Neoplasms: the 159th Biomedical Version of "it Takes Two to Tango"

Overview
Journal Exp Hematol
Specialty Hematology
Date 2018 Dec 30
PMID 30593829
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The role of stem cells in normal and neoplastic hematopoiesis is well established. However, neither normal nor neoplastic hematopoietic stem cells (HSCs) develop in isolation and accumulating evidence indicates that a critical developmental role is played by the perivascular "niche." The cellular, humoral, and cell surface contacts that provide the proper environment for HSC survival, proliferation, and differentiation are becoming increasingly better understood. A number of studies have established that endothelial cells (ECs), several types of perivascular stromal cells, and megakaryocytes (MKs) provide several cell surface and secreted molecules required for HSC development. Accumulating evidence also indicates that the normal stem cell niche is altered in patients with hematological neoplasms and that the "neoplastic niche" plays an important role in promoting malignant and suppressing normal blood cell development in such patients. To explore this concept in the myeloproliferative neoplasms (MPNs), we employed a murine model to determine the effects of Jak2VF, an oncogene found in a majority of such patients, in marrow ECs and MKs and their effect on promoting neoplastic and suppressing normal hematopoiesis. We found that Jak2VF has profound effects on both cell types, which together are critical for the growth advantage and radioresistance shown by Jak2VF-bearing HSCs. Such findings should provide new approaches to the treatment of patients with MPNs.

Citing Articles

The possible role of mutated endothelial cells in myeloproliferative neoplasms.

Farina M, Russo D, Hoffman R Haematologica. 2021; 106(11):2813-2823.

PMID: 34320782 PMC: 8561279. DOI: 10.3324/haematol.2021.278499.


Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm.

Castiglione M, Jiang Y, Mazzeo C, Lee S, Chen J, Kaushansky K J Thromb Haemost. 2020; 18(12):3359-3370.

PMID: 32920974 PMC: 7756295. DOI: 10.1111/jth.15095.


Amino Acid-Mediated Metabolism: A New Power to Influence Properties of Stem Cells.

Liu J, Qin X, Pan D, Zhang B, Jin F Stem Cells Int. 2019; 2019:6919463.

PMID: 31885621 PMC: 6915148. DOI: 10.1155/2019/6919463.


Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia.

Ishikawa G, Fujiwara N, Hirschfield H, Varricchio L, Hoshida Y, Barosi G Exp Hematol. 2019; 79:16-25.e3.

PMID: 31678370 PMC: 6910948. DOI: 10.1016/j.exphem.2019.10.001.

References
1.
Rosti V, Villani L, Riboni R, Poletto V, Bonetti E, Tozzi L . Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation. Blood. 2012; 121(2):360-8. DOI: 10.1182/blood-2012-01-404889. View

2.
Lin C, Kaushansky K, Zhan H . JAK2-mutant vascular niche contributes to JAK2 clonal expansion in myeloproliferative neoplasms. Blood Cells Mol Dis. 2016; 62:42-48. PMC: 5135612. DOI: 10.1016/j.bcmd.2016.09.004. View

3.
James C, Ugo V, Le Couedic J, Staerk J, Delhommeau F, Lacout C . A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005; 434(7037):1144-8. DOI: 10.1038/nature03546. View

4.
Zhang Y, Lin C, Kaushansky K, Zhan H . JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice Through Thrombopoietin/MPL Signaling. Stem Cells. 2018; 36(11):1676-1684. PMC: 6819142. DOI: 10.1002/stem.2888. View

5.
Kaushansky K, Lok S, Holly R, Broudy V, Lin N, BAILEY M . Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994; 369(6481):568-71. DOI: 10.1038/369568a0. View